Registration for a live webinar on 'Innovative Vaccines and Viral Pathogenesis: Insights from Recent Monkeypox Research' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Topics covered
- What problems are we addressing – 1
- What problems are we addressing – 2
- What is DMDI?
- ICF framework
- ICF components
- Impairments
- Chronic ulcer in person affected by leprosy
- Lymphoedema in lymphatic filariasis
- Mental wellbeing and depression
- Depression
- Impact on functioning
- Activity limitations and participation restrictions
- Impact of and on personal factors
- Internalised stigma for those affected by leprosy
- Impact of environment
- Public stigma (social distance)
- Lymphoedema self-care
- The Journey Through Care
- DMDI and Universal Health Coverage
- Integrating DMDI in NTD programmes
- Priorities for DMDI in endemic areas
- Cross-NTD initiatives
- Skin and wound care through self-care groups
- Examples of cross-NTD initiatives
- Take home messages
- Thank you
Topics Covered
- Problems for NTD management
- Disease management, disability and inclusion (DMDI)
- DMDI and the WHO International Classification of Functioning, Disability & Health (ICF)
- The Journey Through Care
- DMDI and Universal Health Coverage
- Integrating DMDI in NTD programmes
- Priorities for DMDI in endemic areas
Links
Series:
Categories:
Therapeutic Areas:
External Links
Talk Citation
Brakel, W.H.V. (2019, November 28). NTD-related disease management, disability and Inclusion (DMDI) [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved November 8, 2024, from https://doi.org/10.69645/VLAV6400.Export Citation (RIS)
Publication History
Financial Disclosures
- Dr. Wim H van Brakel has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
HSTalks is pleased to grant unrestricted complimentary access to all lectures in the series Neglected Tropical Diseases. Persons not at a subscribing institution should sign up for a personal account.
Other Talks in the Series: Neglected Tropical Diseases
Transcript
Please wait while the transcript is being prepared...
0:00
The title of this presentation is "NTD-related Disease Management, Disability,
and Inclusion abbreviated to DMDI".
My name is Wim van Brakel,
I'm Medical Director at NLR,
an NGO with a track record of more than 50 years in the fight against leprosy.
I'm also the incoming Chair of the DMDI Cross-Cutting Group,
which is one of the cross-cutting groups of the NNN Network,
the NTD NGO Network.
0:29
The topics I hope to cover in
this presentation are, what problems are we actually addressing?
What is DMDI?
DMDI and the WHO International Classification of Functioning,
Disability, and Health also known as the ICF.
We'll have a look at the journey through care at DMDI and
universal health coverage at integrating DMDI in NTD programs,
and at priorities for DMDI in endemic areas.
1:02
What problems are we addressing?
Neglected Tropical Diseases or NTDs are very common in low and middle-income countries.
More than one billion people are estimated to be affected worldwide.
Many millions of people live with long-term consequences of NTDs,
and this is much less known.
Leprosy, lymphatic filariasis, and other NTDs cause severe complications.
These disease complications are often detected late and not treated well,
and this leads to new disabilities and also chronic morbidity for the persons affected.
Examples are wounds on the skin,
nerve damage which may lead to wounds on limbs or hands and feet as in leprosy,
and well-known lymphoedema as a complication of lymphatic filariasis or podoconiosis.